Putnam BioRevolution ETF (SYNB) Chart & Stock Price History $30.31 +0.24 (+0.80%) Closing price 04:10 PM EasternExtended Trading$30.31 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Stock Price Performance The Putnam BioRevolution ETF (SYNB) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 7.11%, with a year-to-date return of 2.50%. In the past month, the fund has increased 6.05%, reflecting recent market activity. As of the latest close, Putnam BioRevolution ETF traded at $30.07 with a market cap of $5.11 million and volume of 110 shares. Receive SYNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.20%1 Month Performance+6.05%3 Month Performance+8.25%Year-To-Date Performance+2.50%1 Year Performance-7.11% SYNB Stock Chart for Tuesday, August, 19, 2025 SYNB Chart by TradingView Putnam BioRevolution ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/18/2025$30.12$30.07-0.17%$30.07$30.07110 shs$5.11 million08/15/2025$29.95$30.12+0.57%$30.12$30.1215 shs$5.12 million08/14/2025$29.99$29.95-0.13%$29.95$29.9515 shs$5.09 million08/13/2025$29.52$29.99+1.59%$29.99$29.995 shs$5.10 million08/12/2025$29.01$29.52+1.76%$29.52$29.34100 shs$5.02 million08/11/2025$28.98$29.01+0.10%$29.11$29.01302 shs$5.08 million08/08/2025$28.96$28.98+0.07%$28.98$28.981 shs$5.07 million08/07/2025$28.92$28.96+0.14%$28.96$28.9650 shs$5.07 million08/06/2025$29.47$28.92-1.87%$28.92$28.922 shs$5.06 million08/05/2025$29.42$29.47+0.17%$29.47$29.471,075 shs$5.16 million Get the Latest News and Ratings for SYNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. 08/04/2025$29.06$29.42+1.24%$29.42$29.291,075 shs$5.15 million08/01/2025$28.96$29.06+0.35%$29.06$29.0685 shs$5.09 million07/31/2025$29.31$28.96-1.19%$28.96$28.96394 shs$5.07 million07/30/2025$29.50$29.31-0.64%$29.31$29.31394 shs$5.13 million07/29/2025$29.60$29.50-0.34%$29.50$29.502 shs$5.16 million07/28/2025$29.78$29.60-0.60%$29.61$29.612 shs$5.18 million07/25/2025$29.77$29.78+0.03%$29.90$29.681,027 shs$5.21 million07/24/2025$29.59$29.77+0.61%$29.77$29.77254 shs$5.21 million07/23/2025$28.85$29.59+2.56%$29.63$29.561,385 shs$5.18 million07/22/2025$28.37$28.85+1.69%$28.85$28.853,481 shs$5.05 million07/21/2025$28.58$28.37-0.73%$28.37$28.373,481 shs$4.97 million07/18/2025$28.82$28.58-0.83%$28.58$28.583,481 shs$5.00 million Related Companies TEC Stock Chart DARP Stock Chart CLDL Stock Chart EVAV Stock Chart WCEO Stock Chart GBLD Stock Chart RYSE Stock Chart RAYS Stock Chart EFRA Stock Chart CLNR Stock Chart Receive SYNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:SYNB) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access